| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 409 | 9.750 | 15.663 | 14.475 | 13.660 |
| Total Income - EUR | - | - | - | - | - | 409 | 9.750 | 15.663 | 14.475 | 13.660 |
| Total Expenses - EUR | - | - | - | - | - | 0 | 414 | 1.420 | 2.334 | 11.587 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 409 | 9.336 | 14.243 | 12.141 | 2.073 |
| Net Profit/Loss - EUR | - | - | - | - | - | 397 | 9.044 | 13.773 | 10.190 | 1.499 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Loredmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 7.808 |
| Current Assets | - | - | - | - | - | 451 | 9.609 | 15.291 | 11.873 | 25.277 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 2.317 | 6.431 |
| Cash | - | - | - | - | - | 451 | 9.609 | 15.291 | 9.556 | 18.845 |
| Shareholders Funds | - | - | - | - | - | 438 | 9.472 | 15.164 | 11.156 | 3.983 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 12 | 136 | 128 | 717 | 29.102 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Loredmed S.r.l.